Differential blockade of morphine and morphine-6 beta-glucuronide analgesia by antisense oligodeoxynucleotides directed against MOR-1 and G-protein alpha subunits in rats.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Neuroscience Letters

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 8592651
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antisense Oligodeoxynucleotides to the Cloned δ Receptor DOR‐1: Uptake, Stability, and Regulation of Gene Expression

  1995cited by this paper
• An antisense oligodeoxynucleotide to mu-opioid receptors inhibits mu-opioid receptor agonist-induced analgesia in rats.

  1995cited by this paper
• Morphine‐6‐glucuronide concentrations and opioid‐related side effects: a survey in cancer patients

  1995cited by this paper
• Antisense mapping the MOR‐1 opioid receptor: evidence for alternative splicing and a novel morphine‐6β‐glucuronide receptor

  1995cited by this paper
• Alkylation of mu opioid receptors by beta-funaltrexamine in vivo: comparison of the effects on in situ binding and heroin self-administration in rats.

  1995cited by this paper
• An opiate-receptor gene family reunion.

  1994cited by this paper
• Blockade of morphine analgesia by an antisense oligodeoxynucleotide against the mu receptor.

  1994cited by this paper
• Biochemical and pharmacological characterization of mu, delta and kappa 3 opioid receptors expressed in BE(2)-C neuroblastoma cells.

  1994cited by this paper
• Genomic structure analysis of promoter sequence of a mouse mu opioid receptor gene.

  1994cited by this paper
• Selective loss of delta opioid analgesia and binding by antisense oligodeoxynucleotides to a delta opioid receptor.

  1994cited by this paper
• Mu and delta opioid synergy between the periaqueductal gray and the rostro-ventral medulla.

  1994cited by this paper
• Cloning, characterization, and distribution of a mu-opioid receptor in rat brain.

  1994cited by this paper
• Human mu opiate receptor. cDNA and genomic clones, pharmacologic characterization and chromosomal assignment.

  1994cited by this paper
• Diffusion of morphine-6-beta-D-glucuronide into the neonatal guinea pig brain during drug-induced respiratory depression.

  1994cited by this paper
• Murine chromosomal location of the mu and kappa opioid receptor genes.

  1994cited by this paper
• G-protein antisense oligodeoxyribonucleotides and mu-opioid supraspinal antinociception.

  1994cited by this paper
• Molecular cloning and functional expression of a mu-opioid receptor from rat brain.

  1993cited by this paper
• Synergistic brainstem interactions for morphine analgesia.

  1993cited by this paper
• Primary structures and expression from cDNAs of rat opioid receptor delta- and mu-subtypes.

  1993cited by this paper
• Gx/z and Gi2 transducer proteins on mu/delta opioid-mediated supraspinal antinociception.

  1993cited by this paper
• mu opiate receptor: cDNA cloning and expression.

  1993cited by this paper
• Molecular biology of opioid receptors.

  1993cited by this paper
• Cloning and pharmacological characterization of a rat mu opioid receptor.

  1993cited by this paper
• Pharmacological mechanisms of opioid analgesics.

  1993cited by this paper
• Blockade of morphine analgesia by both pertussis and cholera toxins in the periaqueductal gray and locus coeruleus.

  1990cited by this paper
• Pharmacological characterization of morphine-6 beta-glucuronide, a very potent morphine metabolite.

  1989cited by this paper
• The spinal antinociceptive actions of morphine metabolites morphine-6-glucuronide and normorphine in the rat.

  1989cited by this paper
• Role of mu 1-opiate receptors in supraspinal opiate analgesia: a microinjection study.

  1988cited by this paper
• Morphine-6-glucuronide: analgesic effects and receptor binding profile in rats.

  1988cited by this paper
• Morphine-6-glucuronide, a potent mu agonist.

  1987cited by this paper
• Biochemical basis for analgesic activity of morphine-6-glucuronide. I. Penetration of morphine-6-glucuronide in the brain of rats.

  1973cited by this paper
• Analgesic effect of morphine glucuronides.

  1971cited by this paper

• A 40-year analysis of central neuroanatomical and neurochemical circuits mediating homeostatic intake and hedonic intake and preferences in rodents.

  2025cites this paper
• αN-Acetyl β-Endorphin Is an Endogenous Ligand of σ1Rs That Regulates Mu-Opioid Receptor Signaling by Exchanging G Proteins for σ2Rs in σ1R Oligomers

  2022cites this paper
• Neuroendocrine mechanisms in oxaliplatin-induced hyperalgesic priming

  2022influential citation
• Contribution of G-Protein α-Subunits to Analgesia, Hyperalgesia, and Hyperalgesic Priming Induced by Subanalgesic and Analgesic Doses of Fentanyl and Morphine

  2021cites this paper
• Interactive Mechanisms of Supraspinal Sites of Opioid Analgesic Action: A Festschrift to Dr. Gavril W. Pasternak

  2020cites this paper
• Direct Administration and Gene Modulation Using Antisense Oligonucleotides Within the CNS

  2020cites this paper
• Inhibition of microglial activation in rats attenuates paraventricular nucleus inflammation in Gαi2 protein‐dependent, salt‐sensitive hypertension

  2019cites this paper
• Tetrapeptide Endomorphin Analogs Require Both Full Length and Truncated Splice Variants of the Mu Opioid Receptor Gene Oprm1 for Analgesia.

  2016cites this paper
• Mitragynine/Corynantheidine Pseudoindoxyls As Opioid Analgesics with Mu Agonism and Delta Antagonism, Which Do Not Recruit β-Arrestin-2.

  2016cites this paper
• Opioid doses required for pain management in lung cancer patients with different cholesterol levels: negative correlation between opioid doses and cholesterol levels

  2016cites this paper
• G&agr;i2-Protein–Mediated Signal Transduction: Central Nervous System Molecular Mechanism Countering the Development of Sodium-Dependent Hypertension

  2015cites this paper
• Brain Gαi2-subunit proteins and the prevention of salt sensitive hypertension

  2015influential citation
• Splice variation of the mu-opioid receptor and its effect on the action of opioids

  2014cites this paper
• 3-Methoxynaltrexone is not a selective antagonist for the acute psychomotor stimulating effects of heroin and 6-monoacetylmorphine in mice.

  2014cites this paper
• Stabilization of the μ-Opioid Receptor by Truncated Single Transmembrane Splice Variants through a Chaperone-like Action*

  2013cites this paper
• Studies on the Role of G Protein Alpha Subunits in Opioid Signaling and Behavior.

  2013cites this paper
• Heterogeneity of mu-opioid receptors as one of the factors sensitive to narcotic analgesics

  2013cites this paper
• Levels of heroin and its metabolites in blood and brain extracellular fluid after i.v. heroin administration to freely moving rats

  2013cites this paper
• Mu Opioids and Their Receptors: Evolution of a Concept

  2013cites this paper
• Induction of morphine-6-glucuronide synthesis by heroin self-administration in the rat

  2012cites this paper
• Preclinical pharmacology and opioid combinations.

  2012cites this paper
• Erratum to: Induction of morphine-6-glucuronide synthesis by heroin self-administration in the rat

  2012cites this paper
• Functional selectivity of central Gα‐subunit proteins in mediating the cardiovascular and renal excretory responses evoked by central α2‐adrenoceptor activation in vivo

  2012cites this paper
• Mu opioid receptors in pain management.

  2011cites this paper
• Opioid receptor subtypes: fact or artifact?

  2011cites this paper
• Pleiotropic effects of morphine-6beta-glucuronide.

  2009cites this paper
• Isolation and characterization of new exon 11‐associated N‐terminal splice variants of the human mu opioid receptor gene

  2009cites this paper
• Gnao1 (G alphaO protein) is a likely genetic contributor to variation in physical dependence on opioids in mice.

  2009cites this paper
• The contribution of MOR-1 exons 1-4 to morphine and heroin analgesia and dependence.

  2009cites this paper
• Behavioural sensitization in mice induced by morphine-glucuronide metabolites.

  2008cites this paper
• Central G-alpha subunit protein-mediated control of cardiovascular function, urine output, and vasopressin secretion in conscious Sprague-Dawley rats.

  2008influential citation
• Differential Effect of Morphine and Morphine-6-glucuronide on the Control of Breathing in the Anesthetized Cat

  2008cites this paper
• Morphine and Heroin Differentially Modulate In Vivo Hippocampal LTP in Opiate-Dependent Rat

  2007cites this paper
• Morphine-6-Glucuronide: Morphine's Successor for Postoperative Pain Relief?

  2006cites this paper
• Identification and characterization of six new alternatively spliced variants of the human μ opioid receptor gene, Oprm

  2005cites this paper
• Randomized, Double-blind Study of the Analgesic Efficacy of Morphine-6-Glucuronide versus Morphine Sulfate for Postoperative Pain in Major Surgery

  2005cites this paper
• Morphine‐6‐glucuronide: Actions and mechanisms

  2005cites this paper
• Dynamic medicinal chemistry in the elaboration of morphine-6-glucuronide analogs.

  2005cites this paper
• Morphine 6beta glucuronide: fortuitous morphine metabolite or preferred peripheral regulatory opiate?

  2005cites this paper
• Molecular biology of opioid analgesia.

  2005cites this paper
• Pharmacokinetic-Pharmacodynamic Modeling of Morphine-6-glucuronide-induced Analgesia in Healthy Volunteers: Absence of Sex Differences

  2004cites this paper
• Multiple opiate receptors: déjà vu all over again.

  2004cites this paper
• Endogenous opioids and feeding behavior: a 30-year historical perspective.

  2004cites this paper
• Functional analysis of MOR‐1 splice variants of the mouse mu opioid receptor gene Oprm

  2004cites this paper
• Ten years of antisense inhibition of brain G-protein-coupled receptor function.

  2003cites this paper
• Opioid receptor-induced GTPgamma35S binding during mouse development.

  2003cites this paper
• Comparison of morphine-6-glucuronide and morphine on respiratory depressant and antinociceptive responses in wild type and mu-opioid receptor deficient mice.

  2003cites this paper
• Opioid Receptor-Induced GTPγ35S Binding during Mouse Development

  2003cites this paper
• Feeding induced by food deprivation is differentially reduced by opioid receptor antisense oligodeoxynucleotide probes in rats.

  2003cites this paper
• Role of Giα2‐protein in opioid tolerance and μ‐opioid receptor downregulation in vivo

  2003cites this paper
• Role of G(i)alpha2-protein in opioid tolerance and mu-opioid receptor downregulation in vivo.

  2003cites this paper
• Mu-opioid receptor down-regulation and tolerance are not equally dependent upon G-protein signaling.

  2002cites this paper
• Pharmacological characterization of beta-endorphin- and dynorphin A(1-17)-induced feeding using G-protein alpha-subunit antisense probes in rats.

  2002cites this paper
• Feeding induced by food deprivation is differentially reduced by G-protein alpha-subunit antisense probes in rats.

  2002cites this paper
• Target validation of G-protein coupled receptors.

  2002cites this paper
• Antagonism of the antinociceptive and discriminative stimulus effects of heroin and morphine by 3-methoxynaltrexone and naltrexone in rhesus monkeys.

  2002cites this paper
• Pharmacological characterization of the dermorphin analog [Dmt(1)]DALDA, a highly potent and selective mu-opioid peptide.

  2001cites this paper
• Morphine-6beta-glucuronide and morphine-3-glucuronide, opioid receptor agonists with different potencies.

  2001cites this paper
• Lack of crosstolerance between morphine and morphine-6-glucuronide as revealed by locomotor activity.

  2000cites this paper
• Morphine and morphine-6beta-glucuronide-induced feeding are differentially reduced by G-protein alpha-subunit antisense probes in rats.

  2000cites this paper
• Expression of antinociception in response to a signal for shock is blocked after selective downregulation of mu-opioid receptors in the rostral ventromedial medulla.

  2000cites this paper
• Comparative immunohistochemical distributions of carboxy terminus epitopes from the mu-opioid receptor splice variants MOR-1D, MOR-1 and MOR-1C in the mouse and rat CNS.

  2000cites this paper
• Morphine-6 beta-glucuronide has a higher efficacy than morphine as a mu-opioid receptor agonist in the rat locus coeruleus.

  2000cites this paper
• Morphine-6 b -glucuronide has a higher e(cid:129)cacy than morphine as a mu-opioid receptor agonist in the rat locus coeruleus

  2000cites this paper
• Antinociceptive and behavioral activation responses elicited by d-Pro(2)-endomorphin-2 in the ventrolateral periaqueductal gray are sensitive to sex and gonadectomy differences in rats.

  2000cites this paper
• Comparison of [(3)H]Glyburide binding with opiate analgesia, tolerance, and dependence in ICR and Swiss-Webster mice.

  2000cites this paper
• Differential distribution in rat brain of mu opioid receptor carboxy terminal splice variants MOR‐1C‐like and MOR‐1‐like immunoreactivity: Evidence for region‐specific processing

  2000cites this paper
• In vivo modulation of G proteins and opioid receptor function by antisense oligodeoxynucleotides.

  2000cites this paper
• Reduction of neurotransmitter receptor and G-protein expression in vivo and in vitro by antisense oligodeoxynucleotide treatment.

  2000cites this paper
• Morphine‐6β‐glucuronide has a higher efficacy than morphine as a mu‐opioid receptor agonist in the rat locus coeruleus

  2000cites this paper
• [In vitro investigations of the effect of morphine and its metabolites on the phagocytosis of peripheral mononuclear cells].

  1999cites this paper
• Antagonism of heroin and morphine self-administration in rats by the morphine-6beta-glucuronide antagonist 3-O-methylnaltrexone.

  1999cites this paper
• Time course of changes in mu-opioid receptor mRNA levels in the periaqueductal gray of rat brain by a single or repeated injections of antisense oligodeoxynucleotides.

  1999cites this paper
• Identification and characterization of three new alternatively spliced mu-opioid receptor isoforms.

  1999cites this paper
• Transport of CSF antibodies to Galpha subunits across neural membranes requires binding to the target protein and protein kinase C activity.

  1999cites this paper
• Pharmacological characterization of morphine-6-sulfate and codeine-6-sulfate.

  1999cites this paper
• The delta-opioid receptor: molecular pharmacology, signal transduction, and the determination of drug efficacy.

  1999cites this paper
• Endomorphin-1 and endomorphin-2 show differences in their activation of mu opioid receptor-regulated G proteins in supraspinal antinociception in mice.

  1999cites this paper
• Retention of heroin and morphine–6β–glucuronide analgesia in a new line of mice lacking exon 1 of MOR–1

  1999cites this paper
• Functional blockade of opioid analgesia by orphanin FQ/nociceptin.

  1998cites this paper
• Mu receptor and Gi2alpha antisense attenuate [D-Met2]-FMRFamide antinociception in mice.

  1998cites this paper
• The effects of antisense to Gialpha2 on opioid agonist potency and Gialpha2 protein and mRNA abundance in the mouse.

  1998cites this paper
• Methadone analgesia in morphine-insensitive CXBK mice.

  1998cites this paper
• Potency ratios of morphine and morphine-6beta-glucuronide analgesia elicited from the periaqueductal gray, locus coeruleus or rostral ventromedial medulla of rats.

  1998cites this paper
• Antisense mapping of opioid receptor clones: effects upon 2-deoxy-D-glucose-induced hyperphagia.

  1998cites this paper
• The Pharmacology of Pain

  1997cites this paper
• mu-Opioid receptor-stimulated guanosine-5'-O-(gamma-thio)-triphosphate binding in rat thalamus and cultured cell lines: signal transduction mechanisms underlying agonist efficacy.

  1997cites this paper
• Antisense mapping of the MOR-1 opioid receptor clone: modulation of hyperphagia induced by DAMGO.

  1997influential citation
• Molecular Determinants of Selectivity in 5-Hydroxytryptamine1B Receptor-G Protein Interactions*

  1997cites this paper
• Functionally differentiating two neuronal nitric oxide synthase isoforms through antisense mapping: evidence for opposing NO actions on morphine analgesia and tolerance.

  1997cites this paper
• Opioids binding mu and delta receptors exhibit diverse efficacy in the activation of Gi2 and G(x/z) transducer proteins in mouse periaqueductal gray matter.

  1997cites this paper
• beta-Phenylethylamines and the isoquinoline alkaloids.

  1997cites this paper
• Antisense mapping of MOR-1 in rats: distinguishing between morphine and morphine-6beta-glucuronide antinociception.

  1997cites this paper
• Antisense mapping DOR-1 in mice: further support for delta receptor subtypes.

  1997cites this paper
• Neuroendocrine and behavioral effects of antisense oligonucleotides.

  1997cites this paper
• 3 H-Morphine-6 b-Glucuronide Binding in Brain Membranes and an MOR-1-Transfected Cell Line 1

  1997cites this paper
• 3‐Methoxynaltrexone, a selective heroin/morphine‐6β‐glucuronide antagonist

  1997cites this paper
• G proteins and opioid receptor-mediated signalling.

  1997cites this paper
• Peripheral morphine analgesia: synergy with central sites and a target of morphine tolerance.

  1996cites this paper
• Differential blockade of opioid analgesia by antisense oligodeoxynucleotides directed against various G protein alpha subunits.

  1996cites this paper